Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development

Global Team Addresses the Unique Scientific Needs of Safety Assessment for Biologics BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has formed a global immunology

LabCorp is Scheduled to Present at the 2018 Barclays Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 7, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 2018 Barclays Global Healthcare Conference . LabCorp’s presentation is planned for Wednesday, March 14, 2018 at 9:30 am (ET) . A live audio webcast of the presentation will be available

LabCorp Partners with Cheeriodicals through Community Service Campaign to Florida Hospital Memorial Medical Center and Halifax Health Medical Center

DAYTONA , Fla.--(BUSINESS WIRE)--Mar. 5, 2018-- As part of a community service campaign, an enthusiastic group of LabCorp employees teamed up with Cheeriodicals to assemble and deliver 128 big green boxes to children patients at Florida Hospital Memorial Medical Center and Halifax Health Medical

Covance Enters into Strategic Technology Agreement with GSK

Leverages Covance’s Xcellerate® Informatics Technology Across GSK’s Global Clinical Trials Portfolio BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 28, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has entered into

LabCorp is Scheduled to Present at the 39th Annual Raymond James Institutional Investors Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 23, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 39th Annual Raymond James Institutional Investors Conference . LabCorp’s presentation is scheduled for Tuesday, March 6, 2018 at 8:40 AM (ET) .

LabCorp to Host Investor and Analyst Day on February 27, 2018

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 20, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, will host an Investor and Analyst Day for institutional investors and financial analysts in New York City on Tuesday, February 27, 2018 . The event, which will feature presentations by

LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance

Net Revenue: Q4 of $2.7 billion , up 13% over 2016; Full year of $10.2 billion , up 8% over 2016 Diluted EPS: Q4 of $6.81 , up 289% over 2016; Full year of $12.21 , up 74% over 2016 Adjusted EPS: Q4 of $2.45 , up 14% over 2016; Full year of $9.60 , up 9% over 2016 Free Cash Flow: Q4 of $468 million

LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 19, 2018-- Laboratory Corporation of America ® Holdings (LabCorp) (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE magazine's 2018 List of World’s Most Admired Companies .

Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies

Distinctive development solutions provided by Chiltern®, a Covance® company BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 8, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has introduced a dedicated offering for

LabCorp is Scheduled to Present at the 36th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 36th Annual J.P. Morgan Healthcare Conference . LabCorp’s presentation is scheduled for Tuesday, January 9, 2018 at 9:30 am (PT) . A live audio webcast of the presentation will be